Buyback in the Breach: Munich Re Bets €900 Million on Its Own Stock as Market Stays Skeptical

Munich Re launches €900M buyback as stock nears 52-week low despite 57% Q1 profit surge; currency drag and pricing discipline contrast market pessimism.

Munich Re’s management is putting its money where its mouth is. Since mid-May, the reinsurer has been scooping up its own shares in a first tranche worth up to €900 million, scheduled to run through August. The move is a blunt signal of confidence from a board watching its stock hover less than 2% above a 52-week low, having shed more than 15% in the past month alone.

The disconnect between operational strength and market sentiment is glaring. In the first quarter, net profit surged 57% to €1.71 billion, driven partly by a low comparison base: the prior-year period was hit by roughly €800 million in losses from the California wildfires. Earnings in the property and casualty reinsurance division alone jumped 145%. The combined ratio improved to a stellar 66.8%, beating the analyst consensus of 74.6% by a wide margin.

Yet a powerful headwind has been battering the top line. The euro’s strength shaved 5% off insurance revenue, which fell to €15 billion — a miss against forecasts of an increase. At the start of 2025, one euro bought around $1.03; during the first quarter of 2026, the exchange rate consistently stayed between $1.15 and $1.20. Since many of Munich Re’s contracts are denominated in dollars, the translation hit is direct and painful.

The same currency pressure is compounding a broader pricing challenge. At the key renewal round on April 1, Munich Re absorbed a risk-adjusted price decline of 3.1%. Rather than chase volume at lower rates, the group let its written business shrink by 18.5%, deliberately culling contracts that fell below its minimum return thresholds. That discipline stands in contrast to rival Hannover Re, which chose to expand its book.

Chief Financial Officer Buchanan has described the current pricing environment as “solid” and expects to “largely hold” the level at the next major renewal in July. That promise will be put to a concrete test in the coming weeks, and the market is watching closely.

Munich Re’s full-year guidance remains unchanged: insurance revenue of around €64 billion and net profit of approximately €6.3 billion. The dividend for 2025 has been raised 20% to €24.00 per share, lifting the total capital returned — including the ongoing buyback — to roughly €5.3 billion. The entire share repurchase program runs until the annual general meeting in 2027 and has a maximum volume of €2.25 billion.

Behind the headline numbers, the group is pursuing a deep internal transformation. At its ERGO subsidiary, around 1,000 jobs in Germany are set to disappear by 2030. The company will retrain hundreds of employees while expanding the use of artificial intelligence, with management stressing that headcount reductions will be matched to the actual pace of technology adoption. Annual recurring savings of about €600 million are the target.

The stock closed on Friday at €475.10, roughly 21% below its 52-week high of €605.00. At a price-to-earnings ratio of around 10 for 2026 and a dividend yield of about 5%, the valuation may appear tempting. But with no near-term catalysts on the calendar, the market is holding its fire until the July renewals.

The strategic framework through the rest of the decade calls for annual earnings-per-share growth of more than 8%. Whether that ambition can be realised depends heavily on the summer’s pricing test. If Munich Re succeeds in holding the line against a broad industry downtrend — which rating agency Moody’s attributes to high capital availability and rising competition — the focus will return to the company’s strong underlying performance. For now, the board’s buyback bet is a vote of confidence that the market has yet to endorse.